Hey everyone,
I know this is tough news, but it is what it is..
It became known today that rituximab failed to be clinically effective in the treatment of ME/CFS.
This was confirmed in a letter to the participants from Fluge & Mella.
They emphasized that regardless of the negative result, they now have good data, which will be analyzed for publication in a proper medical journal, and they did not rule out future clinical studies either.
Today they are having a presentation in Oslo. It is being videotaped, so maybe more will be said when that surface.
Updates from Oslo (PS: by word of mouth):
- Cyclo-study looking "positive", but larger studies
problematic due to side effects.
- They don`t know if they will study Rituximab more, if they would they probably have to identify the subgroup.
- Didn`t say more then that the rituximab-study was negative.
I know this is tough news, but it is what it is..
It became known today that rituximab failed to be clinically effective in the treatment of ME/CFS.
This was confirmed in a letter to the participants from Fluge & Mella.
They emphasized that regardless of the negative result, they now have good data, which will be analyzed for publication in a proper medical journal, and they did not rule out future clinical studies either.
Today they are having a presentation in Oslo. It is being videotaped, so maybe more will be said when that surface.
Updates from Oslo (PS: by word of mouth):
- Cyclo-study looking "positive", but larger studies
problematic due to side effects.
- They don`t know if they will study Rituximab more, if they would they probably have to identify the subgroup.
- Didn`t say more then that the rituximab-study was negative.
Last edited: